# Smith & Nephew plc: overview SNN · NYSE · CIK 845982 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/snn.md) · [Financials](/companies/snn/financials.md) · [Filings](/companies/snn/filings.md) · [Insiders](/companies/snn/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [5,212](/filings/0001558370-24-002867.md) | [5,215](/filings/0001558370-25-002550.md) | [5,549](/filings/0001104659-26-028258.md) | [5,810](/filings/0001104659-26-028258.md) | [6,164](/filings/0001104659-26-028258.md) | | Gross margin | % | [70.4%](/filings/0001558370-24-002867.md) | [70.5%](/filings/0001558370-25-002550.md) | [68.8%](/filings/0001104659-26-028258.md) | [69.6%](/filings/0001104659-26-028258.md) | [68.0%](/filings/0001104659-26-028258.md) | | Operating margin | % | [11.4%](/filings/0001558370-24-002867.md) | [8.6%](/filings/0001558370-25-002550.md) | [7.7%](/filings/0001104659-26-028258.md) | [11.3%](/filings/0001104659-26-028258.md) | [12.9%](/filings/0001104659-26-028258.md) | | Net margin | % | [10.1%](/filings/0001558370-24-002867.md) | [4.3%](/filings/0001558370-25-002550.md) | [4.7%](/filings/0001104659-26-028258.md) | [7.1%](/filings/0001104659-26-028258.md) | [10.1%](/filings/0001104659-26-028258.md) | | Diluted EPS | $ per share | [0.60](/filings/0001558370-24-002867.md) | [0.26](/filings/0001558370-25-002550.md) | [0.30](/filings/0001104659-26-028258.md) | [0.47](/filings/0001104659-26-028258.md) | [0.72](/filings/0001104659-26-028258.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/snn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [River Road Asset Management, LLC](/funds/1341401.md) | 2026-06-30 | $92.8m | 3,221,876 | | Reduced −19,874 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $88.4m | 3,069,598 | | Added +606,498 | | [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $61.9m | 2,148,731 | | Added +806,533 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $53.1m | 1,837,261 | | Added +784,514 | | [LMR Partners LLP](/funds/1578621.md) | 2026-06-30 | $50.9m | 1,767,872 | | Unchanged | | [CAUSEWAY CAPITAL MANAGEMENT LLC](/funds/1165797.md) | 2026-06-30 | $45.1m | 1,565,167 | | Added +612,021 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $39.6m | 1,375,531 | | Added +857,880 | | [TODD ASSET MANAGEMENT LLC](/funds/1071483.md) | 2026-06-30 | $36.1m | 1,251,905 | | Reduced −141,417 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $34.7m | 1,204,463 | | Reduced −180,747 | | [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $33.0m | 1,145,234 | | Reduced −1,097,785 | ## Recent filings [All 1,709 filings](/companies/snn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 11:45 ET | [6-K](/filings/0001654954-26-009098.md) | Report of a foreign private issuer, period 2026-10-22 | 0001654954-26-009098 | | 2026-10-08 | 14:55 ET | [6-K](/filings/0001654954-26-008852.md) | Report of a foreign private issuer, period 2026-10-08 | 0001654954-26-008852 | | 2026-10-01 | 10:10 ET | [6-K](/filings/0001654954-26-008692.md) | Report of a foreign private issuer, period 2026-10-01 | 0001654954-26-008692 | | 2026-10-01 | 10:05 ET | [6-K](/filings/0001654954-26-008690.md) | Report of a foreign private issuer, period 2026-10-01 | 0001654954-26-008690 | | 2026-09-18 | 14:06 ET | [6-K](/filings/0001654954-26-008442.md) | Report of a foreign private issuer, period 2026-09-18 | 0001654954-26-008442 | | 2026-09-18 | 10:11 ET | [6-K](/filings/0001654954-26-008434.md) | Report of a foreign private issuer, period 2026-09-18 | 0001654954-26-008434 | | 2026-09-16 | 10:38 ET | [6-K](/filings/0001654954-26-008399.md) | Report of a foreign private issuer, period 2026-09-16 | 0001654954-26-008399 | | 2026-09-16 | 10:29 ET | [6-K](/filings/0001654954-26-008396.md) | Report of a foreign private issuer, period 2026-09-16 | 0001654954-26-008396 | | 2026-09-11 | 17:23 ET | [6-K](/filings/0000950103-26-013824.md) | Report of a foreign private issuer, period 2026-09-11 | 0000950103-26-013824 | | 2026-09-10 | 20:32 ET | [6-K](/filings/0000950103-26-013772.md) | Report of a foreign private issuer, period 2026-09-10 | 0000950103-26-013772 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-028258.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 845982 - Tickers: SNN, SNNUF - Exchange: NYSE - SIC code: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies - State of incorporation: not reported - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.